Gå direkt till huvudinnehållet

S-Cancerantigen 125, CA125

Senast reviderad:
Sakkunnig:


  1. Tuxen MK, Soletormos G, Dombernowsky P. Tumor markers in the management of patients with ovarian cancer. Cancer Treat Rev 1995;21:215-45. PubMed  
  2. Jacobs IJ, Skates SJ, MacDonald N, et al. Screening for ovarian cancer: a pilot randomized controlled trial. Lancet 1999, Apr 10;353:1207-10
  3. Chu MM, FishmanD. Risk assessment for epithelial ovarian cancer: Proposing a new approach to a deadly problem. Scand J Clin Lab Invest 2014;74 suppl 244:63-67. http://www-tandfonline-com/toc/iclb20/74/sup244. PMID: 25083896. PubMed  
  4. Gallup DG, Talledo E. Management of the adnexal mass in the 1990s. South Med J 1997;90:972-81. PubMed  
  5. Nilsson-Ehle P (red.): Laurells Klinisk kemi i praktisk medicin. Lund: Studentlitteratur, 2012
  6. Lyngbye J, Kjær A, Ladefoged S, Nissen PH. Lyngbyes laboratoriemedicin. 2. udg., København: Nyt Nordisk Forlag Arnold Busck A/S, 2010.
  • Anders Kallner, docent och f d överläkare, Karolinska universitetslaboratoriet, Karolinska universitetssjukhuset